Ghada Alomari
Irbid, IR, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling.
Journal: Scientific reports
Published: December 04, 2025
Effects of 1,8-Cineole on Diabetic Muscular Atrophy.
Journal: Current molecular medicine
Published: August 27, 2025
Stigmasterol as a ptotential phytotherapeutic agent for benign prostatic hyperplasia: modulation of inflammation, oxidative stress, and apoptosis.
Journal: Molecular biology reports
Published: April 08, 2025
The Potential Antidiabetic Activity of Novel Nalidixic Acid-Based 1,2,4-Triazole Derivatives.
Journal: Current medicinal chemistry
Published: April 08, 2025
The Effects of 1,8-Cineole Treatment on Benign Prostatic Hyperplasia in Rats.
Journal: Current pharmaceutical biotechnology
Published: September 23, 2024
Edaravone's reno-protective effects against chronic heat-stress exposure.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 31, 2024
Molecular and cellular effects of gold nanoparticles treatment in experimental diabetic myopathy.
Journal: Heliyon
Published: May 06, 2022
Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy.
Journal: Drug delivery and translational research
Published: October 23, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026